238 related articles for article (PubMed ID: 15026987)
1. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
2. Effects of the ligand sequence modifications on the retargeted transduction by the retroviral vector having a ligand-chimeric Env protein.
Miyakawa K; Fujita R; Katane M; Kubo Y; Amanuma H
J Gen Virol; 2008 Dec; 89(Pt 12):3137-3143. PubMed ID: 19008403
[TBL] [Abstract][Full Text] [Related]
3. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
Schnierle BS; Moritz D; Jeschke M; Groner B
Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
[TBL] [Abstract][Full Text] [Related]
4. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
Hatziioannou T; Russell SJ; Cosset FL
Virology; 2000 Feb; 267(1):49-57. PubMed ID: 10648182
[TBL] [Abstract][Full Text] [Related]
6. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
7. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
8. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
9. Intrakines--evidence for a trans-cellular mechanism of action.
Engel BC; Bauer G; Pepper KA; Bockstoce DC; Yu XJ; Chen SY; Kohn DB
Mol Ther; 2000 Feb; 1(2):165-70. PubMed ID: 10933927
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the direct targeting of murine leukemia virus vectors containing peptide ligands in the envelope protein.
Katane M; Takao E; Kubo Y; Fujita R; Amanuma H
EMBO Rep; 2002 Sep; 3(9):899-904. PubMed ID: 12189179
[TBL] [Abstract][Full Text] [Related]
11. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.
Chu TH; Martinez I; Sheay WC; Dornburg R
Gene Ther; 1994 Sep; 1(5):292-9. PubMed ID: 7584094
[TBL] [Abstract][Full Text] [Related]
12. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.
Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL
Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
14. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
[TBL] [Abstract][Full Text] [Related]
15. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
Lavillette D; Boson B; Russell SJ; Cosset FL
J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
[TBL] [Abstract][Full Text] [Related]
16. Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
Benedict CA; Tun RY; Rubinstein DB; Guillaume T; Cannon PM; Anderson WF
Hum Gene Ther; 1999 Mar; 10(4):545-57. PubMed ID: 10094198
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
Chu H; Zhou H; Liu Y; Liu X; Hu Y; Zhang J
Int J Biochem Cell Biol; 2007; 39(1):197-205. PubMed ID: 16973405
[TBL] [Abstract][Full Text] [Related]
18. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
Qi P; Han JX; Lu YQ; Wang CX
Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
[TBL] [Abstract][Full Text] [Related]
19. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
Sparacio S; Pfeiffer T; Holtkotte D; Bosch V
Virology; 2002 Mar; 294(2):305-11. PubMed ID: 12009872
[TBL] [Abstract][Full Text] [Related]
20. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
Zavorotinskaya T; Albritton LM
Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]